Efficacy of <scp>l</scp> ‐Arginine treatment in patients with <scp>HTLV‐1‐associated</scp> neurological disease-Reference-Cited by-同舟云学术

Efficacy of l ‐Arginine treatment in patients with HTLV‐1‐associated neurological disease

Published:2022-12-22 Issue:2 Volume:10 Page:237-245
ISSN:2328-9503
Container-title:Annals of Clinical and Translational Neurology
language:en
Short-container-title:Ann Clin Transl Neurol

Author:

Nozuma Satoshi¹^ORCID,Matsuura Eiji¹,Tashiro Yuichi¹,Nagata Ryusei¹,Ando Masahiro¹,Hiramatsu Yu¹,Higuchi Yujiro¹,Sakiyama Yusuke¹,Hashiguchi Akihiro¹,Michizono Kumiko¹,Higashi Keiko¹,Matsuzaki Toshio²,Kodama Daisuke²,Tanaka Masakazu²,Yamano Yoshihisa³,Moritoyo Takashi⁴,Kubota Ryuji²,Takashima Hiroshi¹

Affiliation:

1. Department of Neurology and Geriatrics Kagoshima University Graduate School of Medical and Dental Sciences Kagoshima Japan

2. Division of Neuroimmunology, Joint Research Center for Human Retrovirus Infection Kagoshima University Kagoshima Japan

3. Division of Neurology, Department of Internal Medicine St. Marianna University School of Medicine Kawasaki Japan

4. Clinical Research Promotion Center The University of Tokyo Hospital Bunkyo‐ku Japan

Publisher

Wiley

Subject

Neurology (clinical),General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/acn3.51715

Reference34 articles.

1. Adult T-cell leukemia: clinical and hematologic features of 16 cases

2. HTLV-I ASSOCIATED MYELOPATHY, A NEW CLINICAL ENTITY

3. ANTIBODIES TO HUMAN T-LYMPHOTROPIC VIRUS TYPE-I IN PATIENTS WITH TROPICAL SPASTIC PARAPARESIS

4. HTLV-I-associated myelopathy

5. Visualization of HTLV-1–Specific Cytotoxic T Lymphocytes in the Spinal Cords of Patients With HTLV-1–Associated Myelopathy/Tropical Spastic Paraparesis

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel insights into human T‐lymphotropic virus type‐1 (HTLV‐1) pathogenesis‐host interactions in the manifestation of HTLV‐1‐associated myelopathy/tropical spastic paraparesis;Reviews in Medical Virology;2024-06-27

2. New Perspectives about Drug Candidates Targeting HTLV-1 and Related Diseases;Pharmaceuticals;2023-11-02